Epiomed Therapeutics Obtains $2,249,999 New Funding

  • Feed Type
  • Date
    5/1/2013
  • Company Name
    Epiomed Therapeutics
  • Mailing Address
    25 Mauchly Irvine, CA 92618
  • Company Description
    The company is developing novel, small molecule anti-emetic and anti-motion sickness compounds.
  • Website
    http://www.epiomed.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,249,999
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.